中文版 | English

在结果中检索

CCPortal

浏览/检索结果: 共2条，第1-2条 帮助

限定条件            
已选(0)清除 条数/页：   排序方式：
Efficacy and safety of chiglitazar, a novel peroxisome proliferator-activated receptor pan-agonist, in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, phase 3 trial (CMAP) 期刊论文
Science Bulletin, 2021, 卷号: 66, 期号: 15
作者:  Ji L.;  Song W.;  Fang H.;  Li W.;  Geng J.;  Wang Y.;  Guo L.;  Cai H.;  Yang T.;  Li H.;  Yang G.;  Li Q.;  Liu K.;  Li S.;  Liu Y.;  Shi F.;  Li X.;  Gao X.;  Tian H.;  Ji Q.;  Su Q.;  Zhou Z.;  Wang W.;  Zhou Z.;  Li X.;  Xu Y.;  Ning Z.;  Cao H.;  Pan D.;  Yao H.;  Lu X.;  Jia W.
收藏  |  浏览/下载：39/0  |  提交时间：2021/09/01
Carfloglitazar  Chiglitazar  Glycemic control  Insulin resistance  PPAR pan-agonist  Type 2 diabetes  
New particle formation and its CCN enhancement in the Yangtze River Delta under the control of continental and marine air masses 期刊论文
ATMOSPHERIC ENVIRONMENT, 2021, 卷号: 254
作者:  Fang X.;  Hu M.;  Shang D.;  Tan T.;  Zhao G.;  Zong T.;  Tang L.;  Ma X.;  Yang X.;  Dong H.;  Yu X.;  Chen S.;  Li X.;  Liu Y.;  Wang H.;  Gao Y.;  Lou S.;  Zhao C.;  Zeng L.;  Lu K.;  Zhang Y.;  Wu Z.;  Guo S.
收藏  |  浏览/下载：28/0  |  提交时间：2022/01/18
Air mass  Cloud condensation nuclei  New particle formation  Sulfuric acid  Yangtze River Delta